Drug Trial Radar · NCT04238481
A Study for Ureter Visualization, Using ASP5354 in Subjects Undergoing Laparoscopic/Minimally Invasive Colorectal Surgery
Last checked: Nov 20, 2026Latest source record: Oct 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13
Actual
Start
Oct 6, 2020
Primary completion
Nov 18, 2021
Study completion Nov 29, 2021
Sponsor
- Lead sponsor
- Astellas Pharma IncAstellas (ALPMY)
- Sponsor type
- Industry
- First posted
- Jan 23, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study was to determine the optimal dose of ASP5354 for ureter visualization in participants undergoing laparoscopic/minimally invasive colorectal surgery This study also investigated the safety, tolerability and the pharmacokinetics of ASP5354 in participants undergoing laparoscopic/minimally invasive colorectal surgery.
Conditions
- Laparoscopic/Minimally Invasive Colorectal Surgery
Interventions
Pudexacianinium chlorideDrug
Intravenous
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Successful Anatomical Visualization of the Index Ureter(s)Time frame: 30 minutes postdose through end of surgery (on day 1)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Center for Colon and Rectal Surgery; AdventHealth Medical Group
Orlando, Florida
Ochsner Medical Center
New Orleans, Louisiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.